Genitourinary Radiology

EAU: Experts highlight imaging advances in prostate cancer screening

By Kate Madden Yee

The European Association of Urology (EAU) is touting four studies that demonstrate the advancement of prostate cancer screening.

March 16, 2026

Esaote showcases prostate imaging technology at EAU 2026

By AuntMinnie.com staff writers

The technology provides automatic analysis of prostate multiparametric MRI volumes and identifies suspicious regions of interest.

March 13, 2026

New MRI scoring system predicts early liver cancer recurrence

By Kate Madden Yee

The system performed better for this indication than pathologic analysis-based prognostic models.

March 10, 2026

Lantheus wins U.S. FDA approval for Pylarify TruVu PSMA-PET imaging agent

By AuntMinnie.com staff writers

The new formulation shares the same diagnostic properties as the original Pylarify but supports higher radioactive concentrations.

March 9, 2026

SIR updates practice guidelines for chronic pelvic pain in women

By AuntMinnie.com staff writers

Up to one-third of women with chronic pelvic pain may have a venous etiology.

March 6, 2026

ECR: Lessons from ACR's improvement initiative on prostate MRI quality

By Kate Madden Yee

Prostate MRI is an essential tool for prostate cancer workup and management, but its image quality can be highly variable.

March 4, 2026

Prostate Cancer Foundation names 2025 Challenge Award recipients

By AuntMinnie.com staff writers

The Prostate Cancer Foundation will award more than $12 million to 12 multi-institutional research teams.

March 3, 2026

Ablation as effective as surgery for treating small kidney cancers

By Kate Madden Yee

In patients with stage T1a kidney cancer, ablation shows comparable progression risk but fewer complications.

March 3, 2026

CEUS outshines color Doppler imaging for indeterminate kidney lesions

By Amerigo Allegretto

CEUS outperformed color Doppler ultrasound in a study focusing on indeterminate kidney lesions.

February 13, 2026

Clinicians, beware: CT diagnostic accuracy varies by adnexal lesion type

By Kate Madden Yee

The modality correctly diagnoses dermoids and simple cysts, but is not as effective at identifying other types of adnexal lesions.

February 11, 2026

Elekta secures U.S. FDA 510(k) clearance for Evo

By AuntMinnie.com staff writers

The company is moving forward with Elekta Evo CT-Linac.

January 16, 2026

Alliance for Clinical Trials in Oncology launches prostate cancer trial

By AuntMinnie.com staff writers

The phase III trial, called RECIPROCAL, will include 1,500 patients with metastatic, castration-resistant prostate cancer.

January 5, 2026

Page 1 of 94

Next Page